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Table 1. Baseline Participant Characteristics 
and Reported Training Intensity
Mean age, years (Range) 46.6	(35-85)
Sex, male (%) 66.7
Average miles/week (%)
   <10 168	(4.3)
   11-20 1003	(25.9)
   21-30 1318	(34.0)
   31-40 769	(19.9)
   41-50 359	(9.3%)
Average training pace, minutes/mile (% 
total)
   <6min/mile 19	(0.5)
   6-7 min/mile 165	(4.3)
   7-8 min/mile 881	(22.8)
   8-9 min/mile 1093	(28.3)
   10-11 min/mile 460	(11.9)
   11-12 min/mile 202	(5.2)
   >12 min/mile 102	(2.6)
Family History of CAD 1566	(40.7)
Hypertension 825	(21.5)
Rx’ed HTN Meds 271	(7.0)
Hypercholesterolemia 858	(22.6)
Rx’ed Cholesterol Meds 246	(6.4)
Diabetes Mellitus 47	(1.2)
Use Analgesic Medicines for 
Running-related Pain 1393	(36.0)
Use Aspirin Daily 208	(5.4)
Financial Disclosures:
Funding for this project was provided, by the Dorothy Rider Health 
Care Trust Fund; a nonprofit community foundation unrestricted grant.”















































Table 2. Potential Confounders and Reported Medica Follow-up
 Low Mileage High Mileage p-Value
Demographics
Median age, years (25-75%) 45	(40-52.2) 45	(40-52) 0.895
Mean age, years (SD) 46.5	(8.62) 46.4	(8.40) 0.758
Sex, %male 58.6 70.3 <0.001
Risk Factors
Hypertension  (%) 263	(22.7) 562	(21.0) 0.256
Family History CAD (%) 483	(41.5) 1083	(40.4) 0.543
Hyperlipidemia (%) 310	(26.9) 548	(20.8) <0.001
Smoking History (%) 379	(32.7 801	(30.1) 0.117
Diabetes  (%) 15	(1.3) 32	(1.2) 0.941
Medicine Use	
Any NSAID use (%) 761	(65.0) 1627	(60.2) 0.005
NSAID use >1 dose/week (%) 252	(21.5) 405	(14.5) <0.001
NSAID use >1 dose/day (%) 20	(1.7) 33	(1.2) 0.285
Daily aspirin use (%) 69	(5.9) 134	(5.0) 0.268
Hyperlipidemia Dx on meds (%) 87	(28.1) 159	(29.0) 0.840
Hypertension Dx on meds (%) 88	(33.5) 183	(32.6) 0.860
Medical Evaluation
Primary doctor visit in past year (%) 675	(59.3) 1488	(56.3) 0.103
No primary doctor identified (%) 51	(4.5) 113	(4.3) 0.849
Had stress test within last 5 years (%) 197	(17.2) 509	(19.3) 0.137
Had ECG within past 5 years (%) 462	(40.6) 1116	(42.5) 0.294
Discussed risk/benefits of running 
with doc (%) 540	(47.0) 1329	(50.5) 0.055
Table 3. Reported Training Characteristics
 Low Mileage High Mileage p-Value
Training Characteristics
Training pace < 8 minutes/mile (%) 164	(14.0) 901	(33.4) <0.001
Competition Characteristics
Longest race marathon or greater (%) 322	(28.9) 1838	(68.2) <0.001
Longest race ultramarathon (%) 23		(2.0) 349	(13.0) <0.001
Compete in triathlons/multisport 
events (%) 427	(36.9) 889	(33.2) 0.029
Miscellaneous	
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Figure 1: Association of Reported NSAID 
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*Adapted from Schnohr et al, Am J Epidemiology, 2013 (reference 2).
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